Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 177.55 USD 0.97% Market Closed
Market Cap: 26B USD

Wall Street
Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 181.47 USD with a low forecast of 131.3 USD and a high forecast of 273 USD.

Lowest
Price Target
131.3 USD
26% Downside
Average
Price Target
181.47 USD
2% Upside
Highest
Price Target
273 USD
54% Upside
Biogen Inc Competitors:
Price Targets
NTLA
Intellia Therapeutics Inc
136% Upside
IMNM
Immunome Inc
29% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
45% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
29% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
36% Upside
XFOR
X4 Pharmaceuticals Inc
110% Upside
ORGO
Organogenesis Holdings Inc
83% Upside
BIOPOR
Bioporto A/S
274% Upside

Revenue
Forecast

Revenue Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 3 years is -1%.

5%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 3 years is 3%.

2%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 3 years is 13%.

2%
Past Growth
13%
Estimated Growth
Estimates Accuracy
19%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIIB's stock price target?
Price Target
181.47 USD

According to Wall Street analysts, the average 1-year price target for BIIB is 181.47 USD with a low forecast of 131.3 USD and a high forecast of 273 USD.

What is Biogen Inc's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 3 years is -1%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 3 years is 3%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 3 years is 13%.

Back to Top